Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by kevin2m4on Sep 18, 2018 12:22pm
105 Views
Post# 28639551

RE:RE:RE:RE:RE:fake

RE:RE:RE:RE:RE:fake
HipForLife wrote: If you want to get back in, buy the warrants (ACB.WT), they are undervalued compared to current price of ACB.

The warrants don't expire until NOV 2, 2020, and the strike price to convert to 1 common share is only 4$. A warrant gives you the right to get 1 common share of the company for 1 warrant+the strike price, at any point in time before the expiry date. So if you believe ACB will go to 20$ before 2020, the math would on the warrant would be:

20$- 4$ strike price+ time value (you get an additional premium when selling on the open market since there is still time left in the contract for the SP to go higher), so that means if ACB is at 20$ the warrant would be at least 16$. When you add time value it would probably be trading closer to 18$ though. They are only 7$ right now so they will have much better gains as the price of ACB increases. I think anything under 10$ will be a great price by friday...but for today I'd say below 8$ is a steal (high was 8.26 yesterday).

Constellation gave WEED a $25 billion valuation in their last investment. Right now ACB has a market cap of just over $8 billion and now they could be working with Coca-Cola.....A $200 billion powerhouse company, which is backed by Warren Buffet. If this deal goes through, ACB will become bigger than WEED. that means the SP is likely to triple by the expiry date of these warrants!!

Do the math for yourself, using an options calculator...A warrant provides leverage, and when you are in a bull market, the more leverage the better!! Hip warrants are also undervalued if interested.

GLTA, HOLD 



giving this a try.

sold 100 canopy
bought 900 acb warrants with change to spare
Bullboard Posts